Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 8/20 | 0.51 |
| ▸ | NAAA | Q02083 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26296600 | 0.84 | ASAH1 (0.62) | HPGDALDH1A1EPHX2 | |
| SCHEMBL8507635 | 0.82 | HPGD (0.68) | HPGDEPHX1ALDH1A1HTTEPHX2 | |
| SCHEMBL24095909 | 0.81 | NPC1 (0.65) | NAAA | |
| SCHEMBL893362 | 0.78 | TRPA1 (0.51) | HPGDEPHX2CYP2C9CYP2C19 | |
| SCHEMBL26914633 | 0.78 | CSNK1E (0.55) | ALDH1A1 | |
| SCHEMBL15093939 | 0.78 | EPHX2 (0.74) | HPGDEPHX1ALDH1A1EPHX2 | |
| SCHEMBL15093399 | 0.78 | EPHX2 (0.74) | HPGDEPHX1ALDH1A1EPHX2 | |
| SCHEMBL15093824 | 0.78 | EPHX2 (0.74) | HPGDEPHX1ALDH1A1EPHX2 | |
| SCHEMBL15093712 | 0.78 | EPHX2 (0.74) | HPGDEPHX1ALDH1A1EPHX2 | |
| SCHEMBL15093656 | 0.78 | EPHX2 (0.74) | HPGDEPHX1ALDH1A1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021252640-A1 | ASPARAGINE DERIVATIVES AND METHODS OF USING SAME | SENDA BIOSCIENCES, INC. (US) | 2021-12-16 | — | — | WO | disclosed |